3,4-Epoxy-1-butene, a reactive metabolite of 1,3

Environmental and Molecular Mutagenesis 47:67^70 (2006)
Brief Communication
3,4-Epoxy-1-butene, a Reactive Metabolite of
1,3-Butadiene, Induces Somatic Mutations in Xpc-null Mice
J.K.Wickliffe,1* L.A. Galbert,1 M.M. Ammenheuser,1 S.M. Herring,1
J. Xie,2 O.E. Masters III,3 E.C. Friedberg,4 R.S. Lloyd,5 and J.B.Ward Jr1
1
Department of Preventive Medicine and Community Health, University of Texas
Medical Branch, Galveston, Texas
2
Department of Pharmacology and Toxicology, University of Texas Medical
Branch, Galveston, Texas
3
Department of Zoology, University of Oklahoma, Norman, Oklahoma
4
Department of Pathology, University of Texas Southwestern Medical Center,
Dallas, Texas
5
Center for Research on Occupational and Environmental Toxicology,
Oregon Health and Science University, Portland, Oregon
Xpc-null (Xpc–/–) mice, deficient in the global
genome repair subpathway of nucleotide excision
repair (NER-GGR), were exposed by intraperitoneal (IP) injection to a 300 mg/kg mutagenic
dose of 3,4-epoxy-1-butene (EB), to investigate
NER’s potential role in repairing butadiene (BD)
epoxide DNA lesions. Mutagenic sensitivity was
assessed using the Hprt assay. Xpc–/– mice were
significantly more sensitive to EB exposure, exhibiting an average 2.8-fold increase in Hprt mutant
frequency (MF) relative to those of exposed Xpcþ/þ
(wild-type) mice. As a positive control for NERGGR, additional mice were exposed by IP injection to a 150 mg/kg mutagenic dose of benzo[a]-
pyrene (B[a]P). The Xpc–/– mice had MFs 2.9-fold
higher than those of exposed Xpcþ/þ mice. These
results suggest that NER-GGR plays a role in recognizing and repairing some of the DNA adducts
formed following in vivo exposure to EB. Additional research is needed to examine the response
of Xpc–/– mice, as well as other NER-deficient
strains, to inhaled BD. Furthermore, it is likely that
alternative DNA repair pathways also are
involved in restoring genomic integrity compromised by BD-epoxide DNA damage. Collaborative studies are currently underway to address
these critical issues. Environ. Mol. Mutagen.
C 2005 Wiley-Liss, Inc.
47:67–70, 2006. V
Key words: epoxybutene; benzo[a]pyrene; Hprt; nucleotide excision repair; Xpc; butadiene
INTRODUCTION
Olefins mediate their genotoxic effects through epoxide
metabolites. One model olefin, 1,3-butadiene (BD), is biotransformed in vivo to three reactive epoxides. These
include an initial epoxide, epoxybutene (EB), and two
secondary epoxides, diepoxybutane (DEB) and epoxybutenediol (EBD). All are documented mutagens, with DEB
presumably representing the ultimate mutagen [reviewed
by Jackson et al., 2000].
Comparatively little is known about the recognition and
repair of the epoxide-DNA adducts that represent the premutagenic lesions. A number of modified nucleotides and
dinucleotides have been detected in vivo and in vitro,
including reaction products resulting from rearrangements
of unstable primary lesions. These include alkylated
bases, predominantly purines, and interstrand crosslinks
[Selzer and Elfarra, 1996, 1999; Tretyakova et al., 1998;
Koc et al., 1999; Koivisto et al., 1999; Solomon, 1999;
C 2005 Wiley-Liss, Inc.
V
Park and Tretyakova, 2004; Zhang and Elfarra, 2004].
Mutational spectra in cultured cells, as well as mice and
humans exposed to BD or BD-epoxides, reveal increases
in specific point mutations (A/T?T/A transversions and
A/T?G/C transitions) and deletions ranging from simple
frameshifts to entire gene regions [Ma et al., 2000; Recio
et al., 2001; Meng et al., 2004]. Studies examining the
mutagenicity of synthesized lesions in vitro indicate that
Grant sponsor: NIEHS; Grant number: ARCH-NIEHS 1 P30-ES06676,
S11 ES-10018, 2R01ES06015-07, T32-ES07254; Grant sponsor: The
Sealy Center for Environmental Health and Medicine.
*Correspondence to: Jeffrey K. Wickliffe. E-mail: [email protected]
Received 26 April 2005; provisionally accepted 5 May 2005; and in final
form 11 June 2005
DOI 10.1002/em.20169
Published online 10 August 2005 in Wiley InterScience (www.interscience.
wiley.com).
68
Wickliffe et al.
TABLE1. Hprt MFs in Lymphocytes From Xpcþ/þ and Xpc/ Mice Exposed to EB or B[a]P
Exposure groupa
Genotype
Animal
identification
number
EB (300 mg/kg)
Xpcþ/þ
Xpcþ/þ
Xpcþ/þ
Xpc/
Xpc/
Xpc/
Xpc/
Xpcþ/þ
Xpcþ/þ
Xpcþ/þ
Xpcþ/þ
Xpc/
Xpc/
Xpcþ/þ
Xpcþ/þ
Xpcþ/þ
Xpc/
Xpc/
Xpcþ/þ
Xpcþ/þ
Xpcþ/þ
Xpc/
Xpc/
Xpc/
A28M09
A28M10
A28M11
A28M12
A28M13
A28M14
A28M15
A28M01
A28M02
A28M03
A28M04
A28M05
A28M06
A22M05
A22M11
A22M17
A22M12
A22M18
A22M01
A22M19
A22M25
A22M02
A22M14
A22M20
Saline
B[a]P (150 mg/kg)c
DMSO
Cloning
efficiency
Proportion of
TG-resistant
clonesb
Hprt MF
(3 106)
0.10
0.15
0.14
0.09
0.11
0.12
0.07
0.14
0.15
0.10
0.12
0.12
0.08
0.15
0.09
0.19
0.08
0.08
0.12
0.21
0.15
0.19
0.04
0.20
11/576
4/420
8/576
9/575
24/576
27/576
14/468
4/576
4/476
3/576
2/576
5/576
7/552
24/192
11/132
55/540
43/180
37/300
7/576
9/564
10/576
13/432
1/529
26/492
4.80
1.55
2.58
4.62
9.32
9.65
1.04
1.27
1.20
1.32
0.71
1.80
4.23
21.67
33.34
14.14
90.46
42.27
2.64
1.92
2.93
3.96
2.15
6.92
a
Mice were exposed by IP injection to EB or B[a]P and to saline or DMSO as vehicle controls.
Represents the number of wells in 96-well plates containing mutant clones relative to the total number of
wells scored.
c
Mice treated with B[a]P served as positive NER-GGR controls.
b
the alkylpurines and their subsequent reaction products
may produce point mutations, and an intrastrand crosslink
may produce deletions [Carmical et al., 2000a,b; Rodriguez et al., 2001; Kanuri et al., 2002].
Because of the broad spectrum of DNA adducts and
mutations caused by the BD-epoxides, multiple DNA
repair pathways are likely involved in maintaining
genomic integrity following exposure. This includes
nucleotide excision repair (NER), which may be essential
for the repair of crosslinked adducts that are principally
formed by DEB [Friedberg et al., 1995]. To examine the
role that NER has in this process, Xpc-null (Xpc–/–) mice,
deficient in NER global genome repair (NER-GGR), were
exposed to EB by injection. These mice were then examined for the induction of somatic mutations, using the
Hprt assay. Increased Hprt mutant frequencies (MFs) in
Xpc–/– mice, compared with Xpcþ/þ mice, would indicate
that NER-GGR is responsible, in part, for maintaining
genomic integrity compromised by BD-epoxides.
MATERIALS AND METHODS
Xpcþ/þ and Xpc–/– C57BL/6 female mice [Cheo et al., 1997] were
exposed by intraperitoneal (IP) injection to a 300 mg/kg mutagenic dose of
3,4-epoxy-1-butene (EB; 98% pure, cat. no. 12,757-4, Sigma-Aldrich, St.
Louis, MO). Three injections of 100 mg/kg EB were delivered at 48-hr
intervals. Xpc–/– littermates were randomly assigned to treatment groups.
Age-matched Xpcþ/þ mice were obtained from Charles River Laboratories
(CRL, Wilmington, MA) and were treated with saline alone as injection
controls. For positive NER controls, additional mice were exposed by IP
injection to 150 mg/kg benzo[a]pyrene (B[a]P; cat. no. B1760, SigmaAldrich) dissolved in dimethylsulfoxide (DMSO). Mice serving as vehicle
controls were injected with DMSO alone. Three injections of 50 mg/kg
B[a]P were delivered at 48-hr intervals. All mice were treated at 5–6
weeks of age and were maintained for 4 weeks after exposure to EB,
before performing the Hprt assay [Skopek et al., 1992; Meng et al., 1998;
Wickliffe et al., 2003]. Mice treated with B[a]P were housed for 10 weeks
before conducting the Hprt assay. All experiments were conducted in
accordance with the Animal Care and Use Committee’s standards, at the
University of Texas Medical Branch, under protocol 880202402. Mice
were provided water and rodent chow (Prolab RMH 2500, LabDiet, Brentwood, MO) ad libitum and maintained on a 12 hr light–dark cycle.
Statistical Analysis
Hprt MFs were analyzed by univariate ANOVA followed by post hoc
mean comparisons (Bonferroni-corrected), using the SPSS program (SPSS,
Chicago, IL). An a < 0.05 was used to determine statistical significance.
RESULTS AND DISCUSSION
Cloning efficiencies, proportion of 6-thioguanine-resistant clones, and Hprt MFs for each mouse used in this
study are presented in Table I. Two mice (M07 and M08)
Nucleotide Excision Repair and Epoxybutene
69
Fig. 1. Mean Hprt MFs in mice exposed to 300 mg/kg EB. Bars represent standard errors of the arithmetic
mean. *Significantly different from all other groups at P < 0.05.
Fig. 2. Mean Hprt MFs in mice exposed to 150 mg/kg B[a]P. Bars represent standard errors of the arithmetic
mean. Note the change in scale for MFs, compared with that in Figure 1. *Significantly different from DMSO
controls at P < 0.05. **Significantly different from all other groups at P < 0.05.
were excluded from the study. M07 had a cloning efficiency of only 0.001, and M08 died immediately following the first injection of 100 mg/kg EB.
3,4-Epoxy-1-butene Exposure
Mice deficient in NER-GGR were more sensitive than
Xpcþ/þ mice to the mutagenic potential of EB, following
exposure. The Xpc–/– mice had significantly higher Hprt
MFs (P < 0.05) than those of Xpcþ/þ mice exposed to EB
and control mice (both Xpcþ/þ and Xpc–/–) exposed to saline alone (Fig. 1). The average 2.8-fold increase in Hprt
MFs in Xpc–/– mice relative to the MFs of Xpcþ/þ mice is
similar to that observed in a recent experiment in which
mice deficient in microsomal epoxide hydrolase (Ephx1null) were exposed to 240 mg/kg EB (data unpublished).
In that experiment, we observed a significant (P < 0.05)
2.9-fold increase in Hprt MFs in Ephx1-null mice, compared with the MFs of exposed Xpcþ/þ mice. This suggests
that, at these approximate levels, EB-exposed mice that
are incapable of recognizing and repairing the BD-epox-
ide DNA lesions that are NER-GGR substrates are as sensitive to the genotoxic effects of BD as Ephx1-null mice
that are incapable of detoxifying the BD-epoxides themselves. In this study, exposed Xpcþ/þ mice exhibited Hprt
MFs that were 2.7-fold higher than those of unexposed
Xpcþ/þ mice.
Benzo[a]Pyrene Exposure
B[a]P is metabolized to a reactive epoxide that forms
bulky DNA adducts that are classic substrates for NER.
Therefore, we exposed Xpcþ/þ and Xpc–/– mice, by IP
injection, to a mutagenic level of B[a]P. All B[a]Pexposed mice exhibited significantly higher Hprt MFs
than those of both Xpcþ/þ and Xpc–/– mice injected with
vehicle (DMSO) alone (Fig. 2). As hypothesized, exposed
Xpc–/– mice were considerably more sensitive to B[a]P,
compared with their Xpcþ/þ counterpart mice. Xpc–/– mice
exhibited Hprt MFs that were 2.9-fold higher than those
of exposed Xpcþ/þ mice and at least 30-fold higher than
those of unexposed control mice (Fig. 2). Considering the
70
Wickliffe et al.
mutagenic response to the BD-epoxide EB, it was suggested that BD-epoxides are comparatively weak mutagens and/or that alternative DNA repair pathways are efficiently removing premutagenic lesions in the Xpc–/– mice.
SUMMARY
This study indicates that exposure to EB results in the
formation of DNA adducts that are recognized and
repaired by NER-GGR, but it remains unclear as to which
adducts are the NER-GGR substrates. Since mice are
capable of generating all of the reactive BD-epoxide
intermediates from EB, it is reasonable to assume that
DEB, formed in vivo, may be the specific epoxide responsible for generating these substrates. Additional studies
are needed to address this hypothesis.
The relevant experiments that are now necessary to better understand the recognition and repair of BD-induced
DNA lesions should involve inhalation exposures to BD
itself. These future studies, which would allow for the
complete in vivo biotransformation of BD, will better
address the genotoxicity and enhanced sensitivity associated with deficiencies in DNA repair. Characterizing
DNA adduct formation in DNA repair-deficient mice and
examining mutation induction and mutational spectra in
reporter genes, such as Hprt, following exposure to BD
will answer important questions regarding formation, recognition, and repair of BD-induced DNA lesions.
ACKNOWLEDGMENTS
We acknowledge the Advanced Research Cooperation
in Environmental Health program (ARCH-NIEHS 1 P30ES06676), the NIEHS Center at UTMB (S11 ES-10018)
and an NIH R01 to JBW (2R01ES06015-07) for funding
support. JKW was supported by a postdoctoral fellowship
from an NIEHS training award to UTMB (T32-ES07254).
OEM was supported by the Summer Undergraduate
Research Program at UTMB that was funded by the Sealy
Center for Environmental Health and Medicine.
REFERENCES
Carmical JR, Kowalczyk A, Zou Y, Van Houten B, Nechev LV, Harris
CM, Harris TM, Lloyd RS. 2000a. Butadiene-induced intrastrand
cross-links: a possible role in deletion mutagenesis. J Biol Chem
275:19482–19489.
Carmical JR, Nechev LV, Harris CM, Harris TM, Lloyd RS. 2000b.
Mutagenic potential of adenine N6 adducts of monoepoxide and
diolepoxide derivatives of butadiene. Environ Mol Mutagen 35:
48–56.
Cheo DL, Ruven HJT, Meira LB, Hammer RE, Burns DK, Tappe NJ,
van Zeeland AA, Mullenders LHF, Friedberg EC. 1997. Characterization of defective nucleotide excision repair in XPC mutant
mice. Mutat Res 374:1–9.
Friedberg EC, Walker GC, Siede W. 1995. DNA Repair and Mutagenesis.
Washington, DC: American Society for Microbiology. 698 pp.
Jackson MA, Stack HF, Rice JM, Waters MD. 2000. A review of the
genetic and related effects of 1,3-butadiene in rodents and
humans. Mutat Res 463:181–213.
Kanuri M, Nechev LV, Tamura PJ, Harris CM, Harris TM, Lloyd RS.
2002. Mutagenic spectrum of butadiene-derived N1-deoxyinosine
adducts and N6,N6-deoxyadenosine intrastrand cross-links in
mammalian cells. Chem Res Toxicol 15:1572–1580.
Koc H, Tretyakova NY, Walker VE, Henderson RF, Swenberg JA. 1999.
Molecular dosimetry of N-7 guanine adduct formation in mice and
rats exposed to 1,3-butadiene. Chem Res Toxicol 12:566–574.
Koivisto P, Kilpelainen I, Rasanen I, Adler ID, Pacchierotti F, Peltonen
K. 1999. Butadiene diolepoxide- and diepoxybutane-derived
DNA adducts at N7 guanine: a high occurrence of diolepoxidederived adducts in mouse lung after 1,3-butadiene exposure. Carcinogenesis 20:1253–1259.
Ma H, Wood TG, Ammenheuser MM, Rosenblatt JI, Ward JB, Jr. 2000.
Molecular analysis of hprt mutant lymphocytes from 1,3-butadiene-exposed workers. Environ Mol Mutagen 36:59–71.
Meng Q, Skopek TR, Walker DM, Hurley-Leslie S, Chen T, Zimmer
DM, Walker VE. 1998. Culture and propagation of Hprt mutant
T-lymphocytes isolated from mouse spleen. Environ Mol Mutagen 32:236–243.
Meng Q, Walker DM, Scott BR, Seilkop SK, Aden JK, Walker VE.
2004. Characterization of Hprt mutations in cDNA and genomic
DNA of T-cell mutants taken from control and 1,3-butadieneexposed male B6C3F1 mice and F344 rats. Environ Mol Mutagen
43:75–92.
Park S, Tretyakova N. 2004. Structural characterization of the major
DNA-DNA cross-link of 1,2,3,4-diepoxybutane. Chem Res Toxicol 17:129–135.
Recio L, Steen A-M, Pluta LJ, Meyer KG, Saranko CJ. 2001. Mutational
spectrum of 1,3-butadiene and metabolites 1,2-epoxybutene and
1,2,3,4-diepoxybutane to assess mutagenic mechanisms. Chem
Biol Interact 135–136:325–341.
Rodriguez DA, Kowalczyk A, Ward JB, Harris CM, Harris TM, Lloyd
RS. 2001. Point mutations induced by 1,2-epoxy-3-butene N1
deoxyinosine adducts. Environ Mol Mutagen 38:292–296.
Selzer RR, Elfarra AA. 1996. Characterization of N1- and N6-adenosine
adducts and N1-inosine adducts formed by the reaction of butadiene monoxide with adenosine: evidence for the N1-adenosine
adducts as major initial products. Chem Res Toxicol 9:875–881.
Selzer RR, Elfarra AA. 1999. In vitro reactions of butadiene monoxide
with single- and double-stranded DNA: characterization and
quantitation of several purine and pyrimidine adducts. Carcinogenesis 20:285–292.
Skopek TR, Walker VE, Cochrane JE, Craft TR, Cariello NF. 1992.
Mutational spectrum at the Hprt locus in splenic T cells of
B6C3F1 mice exposed to N-ethyl-N-nitrosourea. Proc Natl Acad
Sci USA 89:7866–7870.
Solomon JJ. 1999. Cyclic adducts and intermediates induced by simple
epoxides. IARC Sci Pub 150:123–135.
Tretyakova NY, Chiang SY, Walker VE, Swenberg JA. 1998. Quantitative analysis of 1,3-butadiene-induced DNA adducts in vivo and
in vitro using liquid chromatography electrospray ionization tandem mass spectrometry. J Mass Spectrom 33:363–376.
Wickliffe JK, Ammenheuser MM, Salazar JJ, Abdel-Rahman SZ, Hastings-Smith DA, Postlethwait EM, Lloyd RS, Ward JB, Jr. 2003.
A model of sensitivity: 1,3-butadiene increases mutant frequencies and genomic damage in mice lacking a functional microsomal epoxide hydrolase gene. Environ Mol Mutagen 42:106–110.
Zhang XY, Elfarra AA. 2004. Characterization of the reaction products
of 20 -deoxyguanosine and 1,2,3,4-diepoxybutane after acid
hydrolysis: formation of novel guanine and pyrimidine adducts.
Chem Res Toxicol 17:521–528.